Baek Chung Hee, Kim Hyosang, Baek Seung Don, Jang Mun, Kim Wonhak, Yang Won Seok, Han Duck Jong, Park Su-Kil
Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Korean J Intern Med. 2018 Mar;33(2):356-366. doi: 10.3904/kjim.2016.067. Epub 2017 Aug 21.
BACKGROUND/AIMS: Kidney transplantation (KT) reportedly provides a significant survival advantage over dialysis in diabetic patients. However, KT outcome in diabetic patients compared with that in non-diabetic patients remains controversial. In addition, owing to recent improvements in the outcomes of KT and management of cardiovascular diseases, it is necessary to analyze outcomes of recently performed KT in diabetic patients.
We reviewed all diabetic patients who received living donor KT between January 2008 and December 2011. Each patient was age- and sex-matched with two non-diabetic patients who received living donor KT during the same period. The outcomes of living donor KT were compared between diabetic and non-diabetic patients.
Among 887 patients, 89 diabetic patients were compared with 178 non-diabetic patients. The incidence of acute rejection was not different between the diabetic and non-diabetic patients. Urinary tract infection and other infections as well as cardiovascular events occurred more frequently in diabetic patients. However, diabetes, cardiovascular disease, and infection were not significant risk factors of graft failure. Late rejection (acute rejection after 1 year of transplantation) was the most important risk factor for graft failure after adjusting for diabetes mellitus (DM), human leukocyte antigen mismatch, rejection and infection (hazard ratio, 56.082; 95% confidence interval, 7.169 to 438.702; < 0.001). Mortality was not significantly different between diabetic and non-diabetic patients (0 vs. 2, = 0.344 by log-rank test).
End-stage renal disease patients with DM had favorable outcomes with living donor kidney transplantation.
背景/目的:据报道,肾移植(KT)相较于透析,能为糖尿病患者带来显著的生存优势。然而,糖尿病患者与非糖尿病患者的肾移植结果仍存在争议。此外,由于近期肾移植结果及心血管疾病管理方面的改善,有必要分析近期糖尿病患者肾移植的结果。
我们回顾了2008年1月至2011年12月期间接受活体供肾肾移植的所有糖尿病患者。每位患者在年龄和性别上与同期接受活体供肾肾移植的两名非糖尿病患者相匹配。比较糖尿病患者和非糖尿病患者活体供肾肾移植的结果。
在887例患者中,89例糖尿病患者与178例非糖尿病患者进行了比较。糖尿病患者和非糖尿病患者的急性排斥反应发生率无差异。糖尿病患者的尿路感染、其他感染以及心血管事件更为频繁。然而,糖尿病、心血管疾病和感染并非移植失败的显著危险因素。在对糖尿病(DM)、人类白细胞抗原错配、排斥反应和感染进行校正后,晚期排斥反应(移植1年后的急性排斥反应)是移植失败的最重要危险因素(风险比,56.082;95%置信区间,7.169至438.702;P<0.001)。糖尿病患者和非糖尿病患者的死亡率无显著差异(0例对2例,对数秩检验P=0.344)。
终末期肾病合并糖尿病患者接受活体供肾移植的预后良好。